# Janssen-Cilag, S.A. clinical trials: 21 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with Janssen-Cilag, S.A. as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Janssen-Cilag, S.A.: 21 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/janssen-cilag-s-a

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 30, 2026 | NCT07848737 | A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis | Janssen-Cilag, S.A. | Observational | Not yet recruiting | Colitis, Ulcerative, Crohn Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848737) |
| July 20, 2020 | NCT04476446 | An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other... | Janssen-Cilag, S.A. | Phase 3 | Completed | Depression | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04476446) |
| July 2, 2017 | NCT03207282 | Treatment Resistant Depression in America Latina | Janssen-Cilag, S.A. | Observational | Completed | Depressive Disorder, Treatment-Resistant | 1,539 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03207282) |
| April 13, 2015 | NCT02414984 | Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab | Janssen-Cilag, S.A. | Observational | Terminated | Rheumatoid Arthritis | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02414984) |
| June 3, 2013 | NCT01867164 | A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing... | Janssen-Cilag, S.A. | Phase 3 | Completed | Vaginitis, Infectious Vaginosis | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01867164) |
| November 9, 2012 | NCT01724359 | Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia | Janssen-Cilag, S.A. | Phase 4 | Completed | Schizophrenia | 95 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01724359) |
| November 23, 2011 | NCT01478204 | A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease | Janssen-Cilag, S.A. | Observational | Completed | Alzheimer's Disease | 925 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01478204) |
| July 26, 2011 | NCT01402830 | Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl) | Janssen-Cilag, S.A. | Observational | Completed | Cancer Pain | 271 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01402830) |
| June 20, 2011 | NCT01376492 | FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between... | Janssen-Cilag, S.A. | Observational | Completed | Schizophrenia | 709 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01376492) |
| March 7, 2011 | NCT01309373 | An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With... | Janssen-Cilag, S.A. | Observational | Completed | Schizophrenia, Schizoaffective Disorder | 1,809 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01309373) |
| December 17, 2010 | NCT01262534 | A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis. | Janssen-Cilag, S.A. | Observational | Completed | Psoriasis | 1,042 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01262534) |
| August 13, 2010 | NCT01181921 | The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's... | Janssen-Cilag, S.A. | Phase 4 | Terminated | Alzheimer Disease | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01181921) |
| December 18, 2007 | NCT00576017 | A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic... | Janssen-Cilag, S.A. | Phase 4 | Completed | Pain | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00576017) |
| August 13, 2007 | NCT00515489 | Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients | Janssen-Cilag, S.A. | Observational | Terminated | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders | 1,882 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00515489) |
| August 6, 2007 | NCT00511966 | Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With... | Janssen-Cilag, S.A. | Observational | Terminated | Gastroesophageal Reflux | 1,049 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00511966) |
| August 6, 2007 | NCT00511745 | Safety of Rabeprazole in Patients Under Multiple Treatments | Janssen-Cilag, S.A. | Observational | Terminated | Gastroesophageal Reflux, Gastric Ulcer | 2,157 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00511745) |
| August 6, 2007 | NCT00511628 | Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia | Janssen-Cilag, S.A. | Observational | Terminated | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder | 1,717 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00511628) |
| November 14, 2006 | NCT00399334 | PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders | Janssen-Cilag, S.A. | Observational | Completed | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder | 1,607 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00399334) |
| August 1, 2006 | NCT00358852 | Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia | Janssen-Cilag, S.A. | Observational | Completed | Schizophrenia | 2,339 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00358852) |
| January 30, 2006 | NCT00283517 | A Registry of Treatment Adherence for Patients With Schizophrenia | Janssen-Cilag, S.A. | Observational | Completed | Schizophrenia, Psychotic Disorders | 2,046 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00283517) |
| December 12, 2005 | NCT00264069 | ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry | Janssen-Cilag, S.A. | Observational | Completed | Schizophrenia, Bipolar Disorder, Depression, Personality Disorder | 2,622 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00264069) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 3 | 2 |
| Phase 4 | 3 |
| Observational | 16 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 14 |
| Terminated | 6 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Schizophrenia | 9 |
| Psychotic Disorders | 6 |
| Depression | 3 |
| Alzheimer Disease | 2 |
| Sleep Initiation and Maintenance Disorders | 2 |
| Patient Compliance | 2 |
| Cancer Pain | 2 |
| Pain | 2 |
| Gastroesophageal Reflux | 2 |
| Recurrence | 2 |
| Dementia | 1 |
| Sleep Wake Disorders | 1 |
| Arthritis, Rheumatoid | 1 |
| Bipolar Disorder | 1 |
| Personality Disorders | 1 |
| Neoplasms | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Vaginitis | 1 |
| Weight Gain | 1 |
| Colitis, Ulcerative | 1 |
| Crohn Disease | 1 |
| Parasomnias | 1 |
| Psoriasis | 1 |
| Mental Disorders | 1 |
| Stomach Ulcer | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tobacco companies in the United States](https://specstream.ai/data/businesses/tobacco-companies/united-states)
- [Emergency departments in the United States](https://specstream.ai/data/businesses/emergency-departments/united-states)
- [Private jet charter companies in the United States](https://specstream.ai/data/businesses/private-jet-charter-companies/united-states)
- [Business banking companies in the United States](https://specstream.ai/data/businesses/business-banking-companies/united-states)
- [Malaysian restaurants in the United States](https://specstream.ai/data/businesses/malaysian-restaurants/united-states)
- [Women's health clinics in the United States](https://specstream.ai/data/businesses/womens-health-clinics/united-states)
